CAVAQ10 (WACKER)

The most versatile and bioavailable Coenzyme Q10 on the magistral market.

Technology for versatility and bioavailability

CAVAQ10® is an intelligent source of Coenzyme Q10, being 1800% more bioavailable than common coenzymes on the magistral market.

It is coated with γ-Cyclodextrin through an exclusive and patented process, forming a highly stable complex that is easily dispersible in water.

Due to its high bioavailability, it offers benefits at low dosages, facilitating its handling in different pharmaceutical forms, such as capsules, tablets, gummies and functional drinks or foods, allowing it to be included in different routines.

CAVAQ10® is also a sustainable alternative for vegans, as well as being free of allergens and lecithin.

Composition

Ubiquinone and γ-Cyclodextrin

Bioavailability: the key to Coenzyme Q10's success!

Coenzyme Q10 (CoQ10) is a molecule found naturally in all human cells, recognized for its numerous therapeutic benefits, as it plays a central role in energy metabolism.1

Because it is naturally insoluble in water and is considered too large a molecule to be absorbed satisfactorily in the intestine, several studies have shown that successful supplementation with Coenzyme Q10 depends on strategies to increase its bioavailability.1 and 2

With this in mind, an attempt was made to develop a more bioavailable source of Coenzyme Q10. After years of studies, a special coating in γ-cyclodextrin made it possible to obtain CAVAQ10®, which is 1800% more bioavailable than conventional coenzyme Q10 on the market.

This novelty allows it to be administered in low dosages and its dispersibility in water makes the forms for administering the active ingredient more flexible.

REFERENCES:
1 PRAVST, Igor et al. Comparative Bioavailability of Different Coenzyme Q10 Formulations in Healthy Elderly Individuals. Nutrients, [S.L.], v. 12, n. 3, p. 784, Mar. 16, 2020. MDPI AG.

2 Bhagavan H.N., Chopra R.K. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations. Mitochondrion. 2007;7:S78-S88.

3-Mar-13-2023-05-55-31-7968-PM

Usual dosage

30mg to 250mg

International Certificates

Conteúdo Exclusivo

Quer mais informações? Acesse conteúdo exclusivo sobre esse ativo aqui.